Avalo Therapeutics, Inc. (AVTX)

NASDAQ: AVTX · IEX Real-Time Price · USD

15.94

+0.96 (6.41%)

At close: Apr 26, 2024, 4:00 PM

16.00

+0.06 (0.38%)

After-hours: Apr 26, 2024, 7:57 PM EDT

Avalo Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Income	-31.54	-41.66	-84.38	-63.5	-16.07	-40.05	7.77	-16.47	-10.49	-3.52	Upgrade
Depreciation & Amortization	0.16	0.17	1.66	1.84	3.88	4.55	0.43	0.03	0.02	0.03	Upgrade
Share-Based Compensation	3.48	7.55	8.17	6.79	2.53	2.43	1.16	1.69	0.39	1.09	Upgrade
Other Operating Activities	-2.77	7.19	3.66	14.33	-9.48	29.94	3.22	0.18	-0.09	-13.11	Upgrade
Operating Cash Flow	-30.68	-26.75	-70.89	-40.54	-19.13	-3.13	12.58	-14.57	-10.16	-15.52	Upgrade
Capital Expenditures	-0.13	-0.1	-0.11	-0.06	-0.26	-0.56	-0.02	-0.03	-0.02	-0.02	Upgrade
Acquisitions	0	0	0	11.2	-0.18	1.43	-18.89	0	0	0	Upgrade
Other Investing Activities	-	-	-	-	-	-0	-	-	-	-	Upgrade
Investing Cash Flow	-0.13	-0.1	-0.11	11.13	-0.44	0.87	-18.91	-0.03	-0.02	-0.02	Upgrade
Share Issuance / Repurchase	46.29	-14.7	73.86	44.88	13.73	5.01	6.39	2	23.69	0	Upgrade
Debt Issued / Paid	-21.24	0	32.9	0	-0.26	0	-2.37	-3.31	-1.81	9.64	Upgrade
Other Financing Activities	-	-	-	-0.09	-0.92	5.39	-0.28	-0.11	-2.27	14.22	Upgrade
Financing Cash Flow	25.04	-14.7	106.76	44.78	12.56	10.4	3.74	-1.43	19.6	23.86	Upgrade
Net Cash Flow	-5.77	-41.55	35.76	15.38	-7.02	8.14	-2.6	-16.03	9.42	8.32	Upgrade
Free Cash Flow	-30.81	-26.85	-71.01	-40.6	-19.4	-3.69	12.56	-14.61	-10.18	-15.54	Upgrade
Free Cash Flow Margin	-1601.51%	-148.72%	-1315.39%	-606.09%	-287.34%	-52.54%	45.14%	-1266.97%	-	-	Upgrade
Free Cash Flow Per Share	-38.44	-684.40	-1820.68	-1560.99	-1266.51	-305.82	1964.14	-4764.37	-13175.15	-69697.09	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).